GLP-1 in Pennsylvania 2026 — cash-pay telehealth options after PA Medicaid coverage cut, compared with PlexusDx protocols

GLP-1 in Pennsylvania (2026): Cash-Pay Options After Medicaid Cut Coverage | PlexusDx

Pennsylvania Medicaid cut GLP-1 coverage for adult weight loss on January 1, 2026. This guide walks the legal cash-pay telehealth options that ship to PA, the compounded vs FDA-approved branded distinction, real annualized costs, and where PlexusDx Microdose GLP-1 ($129/mo), Semaglutide Injection ($179–$229/mo), and Tirzepatide Injection ($229–$309/mo) sit relative to Eden, Ro, TrimRx, Willow, and MEDVi — with the optional Precision Peptide Genetic Test anchoring dose decisions to your DNA before week one.